What is COR's current stock price?

As of now, COR is trading at $339.98, with a daily change of -0.18%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

COR Stock Analysis & IQ Rating | Cencora

COR

Cencora

$339.98

-$0.61 | -0.18%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$377.54

MKT CAP

$15.03B

52W Low

$223.92

VOL

$381.91K

P/E Ratio

21.93

AVG VOL

$1.63M

RSI

44.52

TREND

Sideways

BQ Stock IQ

Login to see Cencora (COR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

COR Target Price

Login to display

Strengths

COR Rewards

Earnings are forecast to grow

COR Rewards

Upgraded on attractively valued

COR Rewards

Outperform the market

COR Rewards

Expands stock buyback program

COR Price Performance

$368.53 (-7.75%)

$311.77 (+9.05%)

$292.35 (+16.29%)

$240.05 (+41.63%)

1year

6month

3month

1month

COR Risk Level

COR has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

COR Analysts Opinion

COR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

COR Analysts Opinion

COR Analysts opinion is positive and it remained unchanged from the past 3 months

COR Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

100%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

COR Street Sentiment

COR Street Sentiment is extremely bullish and have positive views on the near-term outlook

COR Performance Sentiment

Sentiments overview associated with COR events and the stock performance.

100%

0%

Positive

Negative

13 out of 13
events present

0 out of 13
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$340.61

Resistance
Price

N/A

Current Price Range

$364.72

Show methods +

COR Latest Analysis +

Zacks.com featured highlights include NVIDIA Ralph Lauren Expedia and Cencora. NVIDIA leads a group of stocks near 52-week highs as Zacks highlights momentum-driven upside potential alongside Ralph Lauren Expedia and Cencora.

Tue Dec 23, 2025

$340.61 | +0.14%

Potential

Why Cencora (COR) is a Top Growth Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Wed Dec 17, 2025

$342.96 | +0.36%

Potential

Cencora To Acquire Majority Stake In OneOncology For About $5 Billion . (RTTNews) - Cencora Inc. (COR) on Monday said it has agreed to acquire the majority of the outstanding equity interests it does not already own in OneOncology a physician-led platform for independent oncology practices from alternative asset manager TPG for about $5 billion.

Mon Dec 15, 2025

$350.32 | +1.25%

Activity

Potential

Cencora Strikes $5 Billion OneOncology Deal Pauses Stock Buyback. ) on Monday agreed to acquire the majority stake it does not own in Cencora stock is showing positive momentum. The consideration includes approximately $3.6 billion and retires its existing corporate debt of $1.3 billion for a total consideration of .OneOncology’.s affiliated practices and management will retain a minority interest in OneOncology.The transaction values the OneOncology enterprise at $7.4 billion with an equit

Mon Dec 15, 2025

$350.32 | +1.25%

Activity

Momentum

Potential

Heres Why You Should Add Cencora Stock to Your Portfolio Now. Cencoras United States Healthcare Solutions strength RCA gains and raised FY25 guidance underscore its accelerating growth momentum.

Wed Dec 10, 2025

$340.79 | +1.04%

Potential

Barclays Initiates Coverage of Cencora (COR) with Overweight Recommendation. Fintel reports that on December 9 2025 Barclays initiated coverage of Cencora (NYSE:COR) with a Overweight recommendation. Analyst Price Forecast Suggests 15.77% Upside

Wed Dec 10, 2025

$340.79 | +1.04%

Rating

FAQ About COR Stock Insights

What is COR current stock price?

What are COR stock strengths?

What is COR Risk Level?

What is COR market cap and volume?

What is COR current Stock IQ?

Should I buy COR stock right now?

Is COR a Strong Buy right now?

What does a 'Strong Buy' rating mean for COR?

What does a 'Strong Sell' rating mean for COR?

What factors influence COR's Stock IQ?

Explore our COR Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored COR Stock Strategies
Effective Risk Management

FIND US ON

Receive our COR Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

COR

Cencora

Current Price

$339.98

-$0.61 | -0.18%

52W High

$377.54

MKT CAP

$15.03B

52W Low

$223.92

VOL

$381.91K

P/E Ratio

21.93

AVG VOL

$1.63M

RSI

44.52

TREND

Sideways

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

COR Rewards

Earnings are forecast to grow

COR Rewards

Upgraded on attractively valued

COR Rewards

Outperform the market

COR Rewards

Expands stock buyback program

COR Price Performance

$368.53 (-7.75%)

$311.77 (+9.05%)

$292.35 (+16.29%)

$240.05 (+41.63%)

1year

6month

3month

1month

COR Analysts Opinion

COR Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

COR Analysts Opinion

COR Analysts opinion is positive and it remained unchanged from the past 3 months

COR Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

100%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

COR Street Sentiment

COR Street Sentiment is extremely bullish and have positive views on the near-term outlook

COR Risk Level

COR has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

COR Performance Sentiment

Sentiments overview associated with COR events and the stock performance.

100%

0%

Positive

Negative

13 out of 13
events present

0 out of 13
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$340.61

Resistance
Price

N/A

Current Price Range

$364.72

Show methods +

COR Stock IQ

Login to unlock Cencora (COR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

COR Latest Analysis

Zacks.com featured highlights include NVIDIA Ralph Lauren Expedia and Cencora. NVIDIA leads a group of stocks near 52-week highs as Zacks highlights momentum-driven upside potential alongside Ralph Lauren Expedia and Cencora.

Tue Dec 23, 2025

$340.61 | +0.14%

Potential

Why Cencora (COR) is a Top Growth Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Wed Dec 17, 2025

$342.96 | +0.36%

Potential

Cencora To Acquire Majority Stake In OneOncology For About $5 Billion . (RTTNews) - Cencora Inc. (COR) on Monday said it has agreed to acquire the majority of the outstanding equity interests it does not already own in OneOncology a physician-led platform for independent oncology practices from alternative asset manager TPG for about $5 billion.

Mon Dec 15, 2025

$350.32 | +1.25%

Activity

Potential

Cencora Strikes $5 Billion OneOncology Deal Pauses Stock Buyback. ) on Monday agreed to acquire the majority stake it does not own in Cencora stock is showing positive momentum. The consideration includes approximately $3.6 billion and retires its existing corporate debt of $1.3 billion for a total consideration of .OneOncology’.s affiliated practices and management will retain a minority interest in OneOncology.The transaction values the OneOncology enterprise at $7.4 billion with an equit

Mon Dec 15, 2025

$350.32 | +1.25%

Activity

Momentum

Potential

Heres Why You Should Add Cencora Stock to Your Portfolio Now. Cencoras United States Healthcare Solutions strength RCA gains and raised FY25 guidance underscore its accelerating growth momentum.

Wed Dec 10, 2025

$340.79 | +1.04%

Potential

Barclays Initiates Coverage of Cencora (COR) with Overweight Recommendation. Fintel reports that on December 9 2025 Barclays initiated coverage of Cencora (NYSE:COR) with a Overweight recommendation. Analyst Price Forecast Suggests 15.77% Upside

Wed Dec 10, 2025

$340.79 | +1.04%

Rating

Discover COR Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of COR. We're here to help you make informed investment decisions today.

FIND US ON

Receive our COR Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

COR Stock trends

COR Stock performance

COR Stock analysis

COR investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing COR

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing COR

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

COR Stock Analysis & IQ Rating | Cencora

BQ Stock IQ

COR Target Price

COR Risk Level

COR Analysts Opinion

COR Street Sentiment

COR Performance Sentiment

Technical Price Levels

Explore our COR Stock insights

Receive our COR Daily Alerts

COR Street Sentiment

COR Risk Level

Technical Price Levels

Discover COR Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of COR. We're here to help you make informed investment decisions today.

Receive our COR Daily Alerts

COR Alerts